Profile
ABVC VRTX VRNA REGN ALNY ARGX
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $43.18M $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.02K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Uttam Yashwant Patil Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
Trading
ABVC VRTX VRNA REGN ALNY ARGX
Last Close $2.77 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $4.76 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $0.41 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High -41.81 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 575.61 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ABVC VRTX VRNA REGN ALNY ARGX
1 Month Return -9.33 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return -3.82 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 170.24 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 432.69 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 369.49 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return 284.72 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) -7.5415073052426E+15 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
ABVC VRTX VRNA REGN ALNY ARGX
Asset Growth -47.97 % -0.87 %
Gross Profit Growth 439.22 % 10.25 %
Revenue Growth 234.31 % 11.66 %
Revenue 3 Year -69.27 % 45.6 %
Revenue 5 Year -89.11 % 163.93 %
Revenue 10 Year 3545.91 % 1632.15 %
EBIT Growth 32.29 % -93.69 %
Net Income Growth 37.04 % -114.8 %
Net Income 3 Yeari Growth Per Share 91.81 % -122.89 %
Net Income 5 Yeari Growth Per Share 79.82 % -145.38 %
Net Income 10 Yeari Growth Per Share -3551.24 % 33.84 %
Operating Income Growth 30.47 % -106.08 %
Operating Cash Flow Growth (CFG) 57.29 % -113.93 %
Operating 3 Year CFG 94.89 % -118.65 %
Operating 5 Year CFG 91.35 % -131.3 %
Operating 10 Year CFG -13043.75 % 12.43 %
EPS Growth 76.67 % -114.8 %
EPS Diluted Growth 76.67 % -114.97 %
Book Value Per Share -96.69 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -97.02 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 221.75 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 913.68 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 40.26 % 116.42 %
Free Cash Flow Growth 57.5 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ABVC VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 50.14 % 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -18.82 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM -55.56 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM -33.7 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 93.8 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 99.58 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM -836.32 % 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -110.75 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM 0.28 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM - 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM 17.2 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM 4.51 % 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM 2.41 % 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -0.1 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -0.1 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 2.61 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -448.8 % 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -110.75 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM -24.59 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -29.51 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -29.51 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ABVC VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 99.85% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -0.42 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ABVC VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.01B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.01B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ABVC VRTX VRNA REGN ALNY ARGX
Net Income $-0.01B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.05
AARD Aardvark Therapeutics, Inc. Common Stock 10.8826
ABCL AbCellera Biologics Inc. 5.4888
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.2869
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.2776
ABPWW 0.0143
ABSI Absci Corporation 4.235
ABUS Arbutus Biopharma Corporation 4.875
ABVX Abivax SA American Depositary Shares 104.208
ACAD ACADIA Pharmaceuticals Inc. 22.83
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7963
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.045
ACIU AC Immune SA 3.625
ACLX Arcellx, Inc. 87.755
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 335.96
VXF Vanguard Extended Market Index Fund 0.00061 211.54
IWC iShares Micro-Cap ETF 0 156.245
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00061 160.9
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00061 160.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00061 397.07
Unlock